Conseco, Inc. Files Registration Statement.Business Editors CARMEL, Ind IND Investigational new drug Therapeutics A status assigned by the FDA to a drug before allowing its use in humans, exempting it from premarketing approval requirements so that experimental clinical trials may be conducted. See Phase 1.2, 3 studies, Sponsorship. .--(BUSINESS WIRE)--Jan. 29, 2004 Conseco, Inc. (NYSE NYSE See: New York Stock Exchange :CNO CNO abbr. chief of naval operations ) today announced that it has filed a registration statement with the Securities and Exchange Commission (the "SEC") on Form S-1 to register the offer and sale of $800,000,000 of common stock and $350,000,000 of a new class of mandatorily convertible preferred stock Convertible Preferred Stock Preferred stock that includes an option for the holder to convert the preferred shares into a fixed number of common shares, usually anytime after a predetermined date. Also known as "convertible preferred shares". . The registration statement has not been declared effective by the SEC, and the securities covered by the registration statement may not be sold nor may any offers to buy be accepted prior to the time that the registration statement becomes effective. This press release is not an offer to sell or the solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Conseco has also withdrawn a universal shelf registration statement on Form S-3, which previously was filed with the SEC on December 5, 2003. The universal shelf registration statement was not declared effective by the SEC and no securities were sold under this registration statement. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion